Assessing Oddity Tech (ODD) Valuation After Weak Earnings And Steep Revenue Guidance Cut

Why Oddity Tech’s latest earnings and outlook matter for investors

Oddity Tech (ODD) recently reported a swing from profit to net loss alongside lower first quarter sales, and guided to a 25% to 30% year-over-year net revenue decline for the second quarter.

This combination of weaker recent results and cautious guidance has sharpened investor focus on Oddity Tech’s growth profile, profitability path, and how the stock’s sharp pullback over the past month and past 3 months fits into the story.

See our latest analysis for Oddity Tech.

The latest guidance for a 25% to 30% year-over-year net revenue decline in the second quarter appears to have weighed heavily on sentiment. The stock’s 30-day share price return is down 32.87% and its 1-year total shareholder return is down 86.73%, pointing to fading momentum despite a recent 1-day share price gain of 4.17% to US$10.25.

If this sharp move has you reassessing where growth and risk are being repriced, it could be a useful moment to scan 20 top founder-led companies

With guidance pointing to weaker near term revenue and the stock down sharply over the past year, the key question is whether Oddity Tech is now trading below its fundamentals or if the share price already reflects slower growth ahead.

Most Popular Narrative: 36.9% Undervalued

Oddity Tech’s most followed narrative pegs fair value at $16.25 a share versus the last close at $10.25, framing the recent selloff as a potential mispricing to interrogate rather than a verdict.

Upcoming new market launches in medical-grade dermatology and telehealth with Brand 3, leveraging Oddity's large, data-rich user base, AI-driven personalization, and proprietary molecules, introduce an entirely new vertical and customer segment, likely providing incremental and diversified revenue streams that are not factored into near-term outlooks.

Read the complete narrative.

Want to see how steady top line assumptions, firmer margins, and a future earnings multiple are stitched together to reach that fair value? The, often surprising, mix of growth expectations, profitability shifts, and required valuation re rating sits at the heart of this narrative and is worth checking against your own view.

Result: Fair Value of $16.25 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, higher customer acquisition costs and the class action lawsuit around advertising disclosures could pressure margins and sentiment, which may challenge the current undervalued narrative.

Find out about the key risks to this Oddity Tech narrative.

Another angle on what the current price might be saying

Oddity Tech’s own checks send a mixed message. On one hand, the stock trades on a P/E of 11.3x, which looks cheaper than the global Personal Products industry at 18.1x. On the other hand, it sits above the peer average of 8.8x and slightly above a fair ratio of 10.9x, which suggests less room for error if earnings or sentiment weaken further.

For investors weighing whether that gap points to opportunity or valuation risk, the detailed multiple breakdown is worth a closer look, particularly alongside See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If this mix of concern and optimism feels familiar, it is a good time to review the data for yourself and decide where you stand, starting with 2 key rewards and 4 important warning signs.

Looking for more investment ideas?

If Oddity Tech has sharpened your thinking, do not stop there. Broaden your watchlist now so you are not late to the next opportunity.

• Spot potential bargains quickly by scanning companies that screen as 47 high quality undervalued stocks.
• Prioritise resilience by checking out solid balance sheet and fundamentals stocks screener (47 results) for businesses with financial strength at their core.
• Get ahead of the crowd by reviewing the screener containing 22 high quality undiscovered gems that most investors might be overlooking.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com